Showing 1,095 results

Filters Content type: News, Editors' picks Topic: Hepatitis C treatment

Direct-acting antiviral medicines interfere with different steps of the hepatitis C lifecycle. A combination of drugs may be co-formulated into a single pill. Modern treatment typically lasts for two or three months, usually does not cause side-effects and cures more than 95% of treated people.

Access to healthcare

Hepatitis C drug buyers club aims to set up new source of support

Editor's pick
Sydney Morning Herald
28 September 2015
New & experimental hepatitis C treatment

Gilead Announces SVR12 Rates from Four Phase 3 Studies Evaluating a Once-Daily, Fixed-Dose Combination of Sofosbuvir (SOF) and Velpatasvir (VEL) (GS-5816) for the Treatment of All Six Hepatitis C Genotypes

Editor's pick
Gilead press release
21 September 2015
People who inject drugs

What We Talk About When We Talk About Hepatitis C

Editor's pick
Huffington Post
18 September 2015
Hepatitis C treatment

Cost of comprehensive global viral hepatitis prevention and treatment effort might peak at $11 billion in 2025

News
15 September 2015
New & experimental hepatitis C treatment

Ongoing Real World Study Reports High Sustained Viral Response Rates with VIEKIRAX® + EXVIERA® in Genotype 1 Hepatitis C Patients

Editor's pick
AbbVie press release
14 September 2015
Hepatitis C treatment

Medicines Patent Pool looks at hepatitis C

News
8 September 2015
Hepatitis C treatment

People living with hepatitis C in Canada want more information about living well and getting treatment

Editor's pick
CATIE
2 September 2015
Hepatitis C treatment

One in four hepatitis C patients denied initial approval for drug treatment

Editor's pick
Yale News
28 August 2015
Hepatitis C treatment

White House Is Pressed to Help Widen Access to Hepatitis C Drugs via Medicaid

Editor's pick
New York Times
26 August 2015
Hepatitis C treatment

Hepatitis C treatment: Back to the warehouse

Editor's pick
Clinical Liver Disease
26 August 2015
People who inject drugs

While Washington Tackles Opioid Abuse Epidemic, Hepatitis C Treatment Remains Unaffordable

Editor's pick
National Journal
19 August 2015
New & experimental hepatitis C treatment

Hepatitis C patients in England denied lifesaving liver drug

Editor's pick
The Observer
18 August 2015
Hepatitis C treatment

Hepatitis C cure associated with significant improvement in liver stiffness in people with HIV and HCV co-infection

News
17 August 2015
Harm reduction

How the Heroin Crisis Ushered in a Hepatitis C Epidemic

Editor's pick
Boston magazine
12 August 2015
Hepatitis C symptoms & diagnosis

Cirrhosis and decompensation are common among people with chronic hepatitis C

News
11 August 2015
Hepatitis C treatment

Improving access to, and completion of, hepatitis C treatment

Editor's pick
Public Health England
4 August 2015
Hepatitis C treatment

Daclatasvir plus sofosbuvir cures HCV for most people with HIV and HCV co-infection in French compassionate use programme

News
3 August 2015
Hepatitis C treatment

NICE issues appraisal consultation documents for three new hepatitis C therapies

Editor's pick
Hepatitis C Trust
30 July 2015
Pharmaceutical industry

Gilead Profit Tops Estimates as Hepatitis C Drug Sales Surge

Editor's pick
Bloomberg
30 July 2015
Hepatitis C treatment

Merck Targets Toughest Cases to Gain Hepatitis C Foothold

Editor's pick
Bloomberg
29 July 2015
Hepatitis C treatment

Georgia sets sights on eliminating hepatitis C

Editor's pick
WHO Europe
27 July 2015
Hepatitis C transmission & prevention

Viral hepatitis – 400 deaths a day in the WHO European Region could be prevented

Editor's pick
WHO Europe
27 July 2015
New & experimental hepatitis C treatment

FDA approves Technivie for treatment of chronic hepatitis C genotype 4

Editor's pick
FDA
27 July 2015
Hepatitis C treatment

How Sure Is a Cure?

Editor's pick
Poz
20 July 2015